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ABSTRACT
Objective To assess the health beneﬁts of outdoor
walking groups.
Design Systematic review and meta-analysis of walking
group interventions examining differences in commonly
used physiological, psychological and well-being
outcomes between baseline and intervention end.
Data sources Seven electronic databases, clinical trial
registers, grey literature and reference lists in English
language up to November 2013.
Eligibility criteria Adults, group walking outdoors
with outcomes directly attributable to the walking
intervention.
Results Forty-two studies were identiﬁed involving
1843 participants. There is evidence that walking groups
have wide-ranging health beneﬁts. Meta-analysis
showed statistically signiﬁcant reductions in mean
difference for systolic blood pressure −3.72 mm Hg
(−5.28 to −2.17) and diastolic blood pressure
−3.14 mm Hg (−4.15 to −2.13); resting heart rate
−2.88 bpm (−4.13 to −1.64); body fat −1.31%
(−2.10 to −0.52), body mass index −0.71 kg/m2
(−1.19 to −0.23), total cholesterol −0.11 mmol/L
(−0.22 to −0.01) and statistically signiﬁcant mean
increases in VO2max of 2.66 mL/kg/min (1.67–3.65), the
SF-36 (physical functioning) score 6.02 (0.51 to 11.53)
and a 6 min walk time of 79.6 m (53.37–105.84).
A standardised mean difference showed a reduction in
depression scores with an effect size of −0.67 (−0.97
to −0.38). The evidence was less clear for other
outcomes such as waist circumference fasting glucose,
SF-36 (mental health) and serum lipids such as high-
density lipids. There were no notable adverse side effects
reported in any of the studies.
Conclusions Walking groups are effective and safe
with good adherence and wide-ranging health beneﬁts.
They could be a promising intervention as an adjunct to
other healthcare or as a proactive health-promoting
activity.
INTRODUCTION
Regular physical activity positively impacts health
potentially offering similar effects to some drug
interventions in terms of mortality beneﬁts. Indeed,
it has been suggested as an alternative or adjunct to
conventional drug therapy.1 Walking at a pace of 3–
5 m/h (5–8 km/h) expends sufﬁcient energy to be
classiﬁed as moderate intensity2 and is an easy and
accessible way of meeting physical activity recom-
mendations.3 Systematic reviews and meta-analyses
have shown walking to have various health beneﬁts
including positive effects on ﬁtness, fatness and
resting blood pressure,4 blood pressure control,5
weight loss,6 depression7 and cardiovascular disease
risk prevention.8
Despite evidence and government campaigns such
as Change4life9 to promote physically active lifestyles,
few are active enough to be of beneﬁt to general
health. In England, for example, 29% of adults do
less than 30 min of moderate physical activity per
week10 and about 8% do not even walk continuously
for 5 min over 4 weeks.11 The impact of interventions
in primary care to reduce inactivity appears limited;
simple advice to be more active has only moderate yet
short-term effects and an effective way of increasing
physical activity and improving associated health indi-
cators while also making the most efﬁcient use of
doctors’ resources has yet to be determined.12–14
One way to promote and sustain walking beha-
viours at the population level may be through the
provision of outdoor walking groups.15 Walking
groups are typically short walks of under an hour in
the natural environment, run by trained lay people.
An example of such is ‘Walking for Health’, a scheme
originally set up by an Oxford General Practitioner
in 2000. It is England’s largest network of lay-led
health group walks with 70 000 regular walkers,
10 000 volunteer walk leaders and approximately
3000 short walks offered every week.16 Group
walking is a potentially attractive physical activity
intervention that has particular potential to engage
those who are interested in the outdoors, whether
for leisure or as a health intervention and has been
found to be cost-effective in increasing physical activ-
ity.17 Additionally, the dynamics and social cohesion
of walking groups may have supportive effects that
encourage and sustain adherence and positive atti-
tudes towards physical activity,18 companionship and
a shared experience of wellness.19 A systematic
review in 2007 by Ogilvie et al20 concluded that
people could be encouraged to walk more if interven-
tions were tailored to their needs and targeted at the
most sedentary or at those most motivated to change
and that group-based approaches, such as the social
support of walking groups, are one method of deli-
vering this. In a recent review, walking groups were
found to be efﬁcacious at increasing physical activity,
particularly when targeted at older adults.21
However, it remains that the beneﬁts to health from
increasing physical activity are greater than increasing
ﬁtness levels, yet no review to date has attempted to
quantify the wider health beneﬁts of walking groups.
Hence, this review has been undertaken to under-
stand whether there is evidence that outdoor walking
groups show wider health beneﬁts as an intervention
and therefore could be recommended by clinicians.
METHODS
This systematic review followed Cochrane system-
atic review guidelines,22 requirements of the NHS
National Institute of Health Research Centre for
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Reviews and Dissemination23 and the PRISMA statement for
reporting studies that evaluate healthcare interventions.24 25
Methods of the analysis and inclusion criteria were speciﬁed in
advance and documented in a protocol registered as
CRD4201300639723 available at http://www.crd.york.ac.uk/
prospero/
Data sources
We searched using electronic databases; clinical trials registers;
by scanning reference lists of articles and from grey literature.
For the electronic databases, the search with speciﬁc search
terms was applied in to AMED, EMBASE, MEDLINE (R) in
process and other non-indexed citations and PsycINFO (sourced
through OVID); SportDiscus and CINAHL (sourced through
EBSCO) and SCOPUS with no date restriction. Databases were
selected to best represent source material in health, allied
health, physical activity and human science. Clinical trials regis-
ters were searched through the UK clinical trials research
network study portfolio; clinicaltrials.gov and controlledtrials.
com. Grey literature included reports from Natural England,
Walking for Health and the National Institute for Health and
Care Excellence. Additionally, reference lists from included
studies and systematic reviews on exercise and walking were
hand searched. The search was completed in November 2013.
Inclusion criteria were studies of outdoor walking groups
involving adults with measured physiological, psychological or
well-being outcomes. The search was restricted to papers pub-
lished in English. The inclusion criteria are further detailed in
table 1.
Search terms were developed with reference to the previous sys-
tematic reviews on walking20 21 and key words from relevant
studies. They were piloted to ensure that known studies were iden-
tiﬁed. The search syntax for the electronic databases is detailed in
online supplementary information appendix (i). For clinical trials
registers, the only search term was ‘walking’ within the title.
Study selection
All studies where the outcome could be directly attributable to
the group walking were included. This included studies where
walking was the control group. All studies were reviewed by the
ﬁrst reviewer and duplicates or the clearly irrelevant, for
example, walk-in centres, using wii-ﬁt, or studies using children
or animals that had not been screened out by the database ﬁlters
were excluded. A particular issue with the assessment of the
studies was that the phrase ‘walking group’ often related to a
walking arm of a study, or a group within a trial that could
walk, and not a ‘walking group’ per se. Additionally, there was
commonly little information within the abstract about the
setting of the intervention, for example, treadmill or indoor
circuit-based interventions or home-based solo interventions
with physical activity diaries and pedometers. Therefore, most
studies were retrieved as full texts and scanned for intervention
information to ensure that none were excluded incorrectly.
Owing to the generally poor description of the intervention, 40
authors were contacted to conﬁrm whether the study was an
outdoor intervention and that they walked as a group. To
further ensure that studies had been correctly excluded, 15% of
the excluded studies were selected by random number gener-
ation and screened by the second author (AJ). All papers were
found to have been excluded correctly and therefore no further
excluded studies were reviewed.
Data extraction
A data extraction sheet was developed by both authors to sum-
marise the study, the population, walking group characteristics,
the intervention (volume and intensity), adherence and out-
comes. This was piloted on ﬁve manuscripts and reﬁned accord-
ingly. Data were extracted by the ﬁrst reviewer into a coding
frame using Microsoft Excel, synthesised and tabulated.
Risk of bias in individual studies and across studies within
meta-analyses
As not all studies were randomised controlled trials, a tool used
by Ogilvie et al20 was adapted to assess risk of bias and internal
validity26 with nine items on a binary scale. These were:
1. Randomisation: Was there sufﬁcient description of a ran-
domisation process or statistical test to show that compar-
ability between the two groups has been adjusted for (no
explanation scores scored zero)?
2. Exposure: Did the authors show that there was no evidence
of a concurrent intervention which could have inﬂuenced
the results (no explanation scores zero)?
Table 1 Inclusion and exclusion criteria
Inclusion Exclusion
Adults from the age of 19 Youths and children up to and including 18
Interventions where people walk as part of a defined walking group intervention Studies that do not involve a walking group intervention, eg, they walk with a
physiotherapist
Where the walking is group based, or where the walking is predominantly group
based but participants may also walk on their own to supplement this
Participants walking only rarely in groups, or walking on their own, such as
home-based or pedometer-based programmes with no group walking
Walking outdoors or walking predominantly outdoors but occasionally indoors
(eg, inside tracks or shopping malls for weather reasons)
Walking indoors or predominantly indoors
Studies that compare group walking with group Nordic walking where group
walking can be isolated as an intervention and the outcome directly related to
group walking
Studies examining Nordic walking only
Studies with physiological, psychological or well-being outcomes such as blood
profiles (eg, lipids, HbA1c), cardiovascular measures (eg, BP), psychological
(eg, Beck depression inventory), well-being (eg, EQ5D)
Studies where the outcomes are solely physical activity such as step outcomes or logs
of physical activity
Studies where the outcome can directly be related to the walking group intervention Studies with a mixed intervention (eg, walking with calcium supplements or walking
combined with a health education intervention) where the outcome cannot be
isolated and directly attributed to group walking
Papers and documents written in English Papers and documents not written in English
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3. Representativeness: Were the study samples shown to be rep-
resentative of the study population?
4. Comparability: Were baseline characteristics of the interven-
tion comparable with the control or were potential confoun-
ders at baseline appropriately adjusted for in analysis?
5. Attrition: Were numbers of participants at follow-up identiﬁ-
able as at least 80% of the baseline?
6. Follow-up tools: Were valid and reliable tools used to assess
participant outcomes?
7. Follow-up time scale: Was the time to follow-up assessment
of a period no less than 1 month?
8. Precision of the results: Were CIs or p values given?
9. Was there evidence presented that the study was sufﬁciently
powered at follow-up assessment (no evidence or underpow-
ered scores zero)?
Publication bias across studies within the meta-analysis was
tested with funnel plots using SE as the measure of study size on
the vertical axis27 and mean difference on the horizontal.
Synthesis of results and statistical analysis
Data for the ﬁnal studies were synthesised with results for each
study recorded as change from baseline to the end of the inter-
vention (↑↓) with p values where available. Non-signiﬁcant or
imprecise p values, such as p>0.05, were used only when this
was the only available information. No assumptions were made
about walking outside the group provision. To establish the
mean difference between baseline and the end of intervention
for meta-analysis, baseline data with SD and sample size, and
end of intervention data with SD or SE and sample size were
utilised. All data were continuous and a difference in means was
used except for one analysis; for depression a standardised
mean difference was used to account for the different outcome
measurements used in the ﬁve studies. There was no need for
data to be transformed as a reduction in value indicated an
improvement in health in all four outcome measures within this
analysis. A ﬁxed effects model was used for all analyses repre-
senting a more conservative measure than a random effects
model.22 Where data were given for different subgroups, each
was input separately and combined in meta-analyses using the
RevMan software package.28 All results are presented with 95%
CIs. The I² statistic was used to test for heterogeneity. I2 values
of 30–60% and 50–90% were taken to represent moderate and
substantial heterogeneity, respectively (ref. 22, Ch 9.5.2).
RESULTS
The initial database search yielded 5145 citations. In addition,
the other supplementary sources produced a further 60 studies.
Of these 5205 studies, 4627 were removed as duplicates or as
clearly irrelevant after reviewing titles. The abstracts of 578 arti-
cles were screened and any that did not provide enough infor-
mation were retrieved for full-text evaluation. A total of 150
papers were read as full texts to be assessed for eligibility. The
remaining 46 articles were put forward for second review and
independently assessed by the second reviewer (AJ). From this,
10 papers were discussed between the two reviewers. Three
studies were excluded due to a lack of information despite
repeated attempts to contact authors as the reviewers lacked
conﬁdence that the intervention was group based and outdoors.
One was excluded on further discussion due to the walking
being primarily self-directed. In total, 42 studies met the inclu-
sion criteria and were eligible to be included in the synthesis.
Walking groups were used as a control in seven of the studies.
The review ﬂow chart is detailed in online supplementary
ﬁgure S1. The characteristics and synthesised results from all 42
studies are detailed in online supplementary table S1.
All 42 studies were assessed for risk of bias (table 2). No
study was excluded due to a low-quality score. Assessments of
quality were made by the ﬁrst reviewer and 20% of the studies
were chosen by random number generation and checked by the
second reviewer. An inter-rater reliability analysis using the κ
statistic was performed to determine consistency among raters
and found to be κ 0.66 (p<0.001) representing substantial
agreement.
Study characteristics
Although there was no date restriction on the search, 74% of
the articles were studies in the past 10 years suggesting the
recent interest in walking groups, with no papers prior to 1988
meeting the inclusion criteria. Studies were located in 14 differ-
ent countries but predominantly in the USA (n=15). A total of
1843 participants walked in outdoor walking groups with at
least 1488 h of provision (3 studies did not give enough infor-
mation from which to calculate dosage) and a total of 74 023 h
of participant walking time. Walking groups were used with par-
ticipants with a broad range of health conditions: arthritis,29 30
dementia and cognitive impairment,31–33 diabetes,34–36 ﬁbro-
myalgia,37–39 obesity and overweight,40–44 mental health
issues45–49 and Parkinson’s disease50 with 64 different tools
used to test outcomes.
In terms of participants, 76% were women while 43% of the
studies were for women only; there were no studies for men
only. The grand mean age was 58 years with 15 studies speciﬁc-
ally aimed at older participants. There was subanalysis in four
studies: ethnicity,40 intensity47 51 and gender.43 Two studies
were of people with learning disabilities living in care facilities:
one obese adults with Prader-Willi syndrome,52 and the second
the coronary heart disease risk of adults with learning disabil-
ities.43 Eleven studies described the ethnicity of the participants
and 13 studies provided some socioeconomic information.
Brandon and Elliott-Lloyd40 compared the response between
African-American women, and the O’Hara et al44 study was
speciﬁcally for African-American women. Otherwise there was
no evaluation of effect for different ethnicities.
Interventions were varied, in volume and intensity, ranging
from 168 to 8580 min of walking over a period of 3 weeks to
1 year, with intensity ranging from self-selected and low to brisk
walking and high-intensity intervals. Moore-Harrison et al53
speciﬁcally targeted those of low socioeconomic proﬁle, and
Isaacs et al54 provide subanalysis of uptake of walking group
intervention by socioeconomic status. Where supervision was
described, it was by professionals, such as physiotherapists, pos-
sibly as the interventions were part of clinical trials. Where
described, provision was in rural locations in 6 of the studies,
and urban for 15. Where additional information from authors
has been obtained, this has been added to the results table 2
(see online supplementary information). Adherence and adverse
effects are described in 76% of the papers. Mean adherence
(where stated) was 75%. One study notes that adherence was
lower for those without access to private transport.54 For
adverse effects, one study described one fall with a brief absence
from the walking programme,55 one a calf injury46 and one, a
study with participants with Parkinson’s disease, describes one
participant experiencing exercise-induced hypotension after
intense uphill walking in hot weather and four falls on roots
and wet ground.50 Otherwise, either authors state that there
were no injuries, or there is no reference to adverse effects. This
is against a back drop of over 74 000 participant hours.
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Attrition was less clearly described but in one study there was a
participant withdrawal as overweight and self-conscious;45 one
author states that travel to the walking club may have affected
attrition,29 and one describes the different attrition rates
between African-American and white walkers.40
Meta-analysis
Common outcome measures enabled meta-analysis of 17 fre-
quently used outcome measures, summarised in table 3 and pre-
sented in full in online supplementary information appendix
(iii). Statistically signiﬁcant improvements from baseline to end
of intervention were identiﬁed for participants in the
intervention groups for systolic and diastolic blood pressure,
resting heart rate, body fat, body mass index (BMI), total choles-
terol, VO2max, quality of life for physical functioning, 6 min
walk time and depression. For depression, a standardised mean
difference of −0.67 (−0.97 to −0.38) represents a statistically
signiﬁcant moderate effect.22 For other outcomes, the effects
were not statistically signiﬁcant.
There was zero heterogeneity in 12 of the analyses with 4
having an I2 between 28% and 48%. The depression score had an
I2 of 83% suggesting a high level of heterogeneity between the
studies. Using funnel plots, all studies were visually symmetrical
with a narrow spread at the top of the funnel indicating precision
Table 2 Risk of bias for included studies
Risk of bias items
Total scoreAuthor Study type 1 2 3 4 5 6 7 8 9
Armstrong RCT 1 0 1 1 1 1 1 0 1 7
Bjersing RCT 1 0 1 1 1 1 1 1 0 7
Brandon RCT 0 1 1 1 1 1 1 1 1 8
Brosseau RCT 1 0 1 1 0 1 1 1 0 6
Cox RCT 1 1 1 1 1 1 1 1 1 9
Duncan RCT 0 1 1 1 1 1 1 1 0 7
Fisher RCT 1 0 1 1 0 1 1 1 0 6
Gusi RCT 1 0 1 1 1 1 1 1 1 8
Hamdorf RCT 1 1 1 1 0 1 1 1 0 7
Hinkleman RCT 0 1 1 1 0 1 1 1 0 6
Isaacs RCT 1 1 1 1 1 1 1 1 1 9
Kamijo RCT 0 1 1 1 1 1 1 1 0 7
Kayo RCT 1 0 1 1 0 1 1 1 1 7
Legrand RCT 0 0 1 1 1 1 1 1 0 6
Mannerkorpi RCT 1 1 1 1 0 1 1 1 1 8
Moore-Harrison RCT 0 0 1 1 1 1 1 1 0 6
Morrison RCT 0 0 1 1 1 1 1 1 0 6
Negri RCT 1 0 1 1 0 1 1 1 0 6
Palmer RCT 0 1 1 1 1 1 1 0 0 6
Reuter RCT 1 1 1 1 1 1 1 1 1 9
Rooks RCT 1 1 1 1 1 1 1 1 0 8
van Uffelen RCT 1 0 1 1 1 1 1 1 0 7
Callahan Pre–post 0 0 1 1 1 1 1 1 0 6
Dallocchio Pre–post 0 0 1 1 1 1 1 1 0 6
Fantin Pre–post 0 0 1 1 1 1 1 1 1 7
Figard-Fabre Pre–post 0 1 1 1 1 1 1 1 0 7
Gelecek Pre–post 0 1 1 1 1 1 1 0 0 6
Holmberg Pre–post 0 0 1 1 0 1 1 1 0 5
Moss Pre–post 0 0 1 1 1 1 1 0 0 5
O’Halloran Pre–post 0 0 1 1 1 1 1 0 0 5
O’Hara Pre–post 0 0 1 0 1 1 1 0 0 4
Cavanaugh CT 0 1 1 1 1 1 1 1 0 7
Fritz CT 0 0 1 0 1 1 1 1 0 5
Park CT 0 1 1 1 0 1 1 1 0 6
Roberts CT 0 1 1 1 1 1 1 0 0 6
Silverthorn CT 0 1 1 1 1 1 1 0 0 6
Song CT 1 0 1 1 1 1 1 1 1 8
Takahashi CT 0 1 0 1 1 1 1 1 0 6
Thomas CT 0 0 1 1 1 0 1 0 0 4
Cyarto Quasi-experimental 0 1 1 1 1 1 1 1 0 7
McDevitt Quasi-experimental 0 0 1 1 1 1 1 1 0 6
Ng Cohort study 0 0 1 0 1 1 1 0 0 4
(1) Randomisation, (2) exposure, (3) representativeness, (4) comparability, (5) attrition, (6) follow-up tools, (7) follow-up time scale, (8) precision of the results, (9) statistical power.
Grey scale indicates studies included in meta-analysis.
CT, controlled trial; RCT, randomised controlled trial.
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with results close to the pooled estimate and without bias towards
smaller studies (see online supplementary appendix ii).
In order to test if the impact of the group walking was greater
in those with clearly deﬁned morbidity, a sub analysis was com-
pleted for the conditions of overweight or obese (BMI≥25),
Type II diabetes (as deﬁned by authors) and depression (as
deﬁned by authors). For depression and BMI this strengthened
the results. By only including those deﬁned as depressed17 45 47
the effect size became large −0.76 (−1.12 to −0.41). By only
including those with a BMI ≥2517 34 35 40 41 43 54 56 57 the
mean difference increased to −0.75 (−1.26 to −0.24). For gly-
cated haemoglobin (HbA1c) and fasting glucose, only including
those with type II diabetes34 35 the mean differences remained
statistically not signiﬁcant −0.16 (−0.40 to 0.08) and −0.57
(−1.58 to 0.43) respectively.
DISCUSSION
Principal ﬁndings
This systematic review and meta-analysis provides evidence that
outdoor walking groups have health beneﬁts over and above
making people more physically active. Statistically signiﬁcant
improvements were found in a range of widely used measures
of health; systolic and diastolic blood pressure, resting heart
rate, body fat, BMI, total cholesterol, VO2max, depression,
6-min walk time, and quality of life for physical functioning.
This is despite the fact that the majority of the interventions
(75%) were below international moderate activity guidelines
which may account for some of the effect sizes being small.
Walking groups appear an acceptable intervention to partici-
pants with high levels of adherence and a low risk of serious
adverse effects.
Strengths and limitations
The strength of this review is that it has comprehensively sought
out walking group studies. It has extensively analysed 42 differ-
ent studies with 1843 participants involved in over 74 000 par-
ticipant hours of group walking. It has also extracted
information for 17 meta-analyses to provide evidence of health
beneﬁts and within these was generally zero or low
heterogeneity. Limitations of the study are that only manuscripts
published in English were sought. Additionally, the populations
in the included studies are very different with many small
studies. The lack of information on walking dose in many of the
studies mean it was not possible to undertake an analysis of
dose–responses.
Results in context of other published reviews
Kassavou et al21 found that walking groups increase physical
activity. The results from this study extend these ﬁndings by pro-
viding evidence of the wide-ranging health beneﬁts of group
walking.
Clinicians and therapists may however be asked whether
walking in groups has similar health beneﬁts than walking per se
or the use of a pedometer, a widely used method of increasing
walking. To explore this, the results of the meta-analysis within
this study were compared ﬁrst with meta-analyses of walking
and then with pedometers.
In terms of depression, Robertson et al7 in their meta-analysis
of walking using a ﬁxed effects model, found a standardised
mean effect size of −0.86 (−1.12 to −0.61), comparable to the
effect size of −0.67 (−0.97 to −0.38) in this review of group
walking. In terms of cardiovascular health, a systematic review
by Murphy et al4 of walking using a random effects model
found statistically signiﬁcant reductions in body fat, BMI and
diastolic blood pressure and increases in VO2max. The effects
were however of a smaller magnitude than those found in this
study; a reduction of diastolic blood pressure of 1.54 mm Hg
from walking compared with 3.14 mm Hg in group walking; a
reduction in BMI of 0.2 kg/m² compared with 0.7 kg/m2; and a
reduction of body fat of 0.63% from walking compared with a
reduction of 1.31% in group walking. In addition, Murphy et al
did not ﬁnd a statistically signiﬁcant reduction in systolic blood
pressure (−1.06 mm Hg, p=0.316) from walking in contrast
to the signiﬁcant reduction in systolic blood pressure
(−3.72 mm Hg, p<0.001) found from group walking in this
review. Murphy et al4 stated a relative reduction of 0.8% in sys-
tolic and 2% in diastolic blood pressure. This is comparable to a
previous meta-analysis of walking and resting blood pressure58
Table 3 Summary meta-analysis results table: difference between baseline and end of intervention
Outcome measure n Effect 95% CIs Heterogeneity Test for overall effect
Systolic BP (mm Hg) 440 −3.72 (−5.28 to −2.17) χ2=12.02, df=12 (p=0.44); I²=0% z=4.70 (p<0.001)
Diastolic BP (mm Hg) 440 −3.14 (−4.15 to −2.13) χ2=23.16, df=12 (p=0.03); I²=48% z=6.09 (p<0.001)
Resting HR (bpm) 252 −2.88 (−4.13 to −1.64) χ2=2.96, df=7 (p=0.89); I²=0% z=4.53 (p<0.001)
Body fat (%) 328 −1.31 (−2.10 to −0.52) χ2=4.00, df=6 (p=0.68); I²=0% z=3.25 (p=0.001)
Body mass index (kg/m2) 451 −0.71 (−1.19 to −0.23) χ2=5.52, df=11 (p=0.90); I²=0% z=2.92 (p=0.003)
Total cholesterol (mmol/L) 271 −0.11 (−0.22 to −0.01) χ2=12.58, df=9 (p=0.18); I²=28% z=2.13 (p=0.03)
VO2max (mL/kg/min) 166 2.66 (1.67 to 3.65) χ
2=9.67, df=6 (p=0.14); I²=38% z=5.28 (p<0.001)
SF-36 score (physical functioning) (points) 68 6.02 (0.51 to 11.53) χ2=0.26, df=1 (p=0.61); I²=0% z=2.14 (p=0.03)
6 min walk time (m) 65 79.6 (53.37 to 105.84) χ2=0.71, df=1 (p=0.40); I²=0%, z=5.95 (p≤0.001)
Depression score*(effect size) 101 −0.67 (−0.97 to −0.38) χ2=24.14, df=4 (P≤0.001); I²=83% z=4.44 (p≤0.001)
Waist circumference (cm) 35 −3.55 (−8.08 to 0.98) χ2=0.52, df=1 (p=0.47); I²=0% z=1.54 (p=0.12)
HbA1c (%) 66 −0.11 (−0.25 to 0.03) χ2=1.17, df=3 (p=0.76); I²=0% z=1.53 (p=0.13)
Fasting glucose (mmol/L) 85 −0.09 (−0.28 to 0.11) χ2=3.33, df=4 (p=0.50); I²=0% z=0.87 (p=0.38)
Low-density lipids (mmol/L) 268 −0.05 (−0.16 to 0.06) χ2=8.83, df=9 (p=0.45); I²=0%, z=0.93 (p=0.35)
High-density lipids (mmol/L) 251 0.01 (−0.04 to 0.07) χ2=8.04, df=8 (p=0.43); I²=0% z=0.45 (p=0.65)
Triglycerides (mmol/L) 271 −0.05 (−0.12 to 0.03) χ2=13.39, df=9 (p=0.15); I²=33% z=1.25 (p=0.21)
SF-36 score (mental health index) (points) 68 2.70 (−2.09 to 7.48) χ2=0.18, df=1 (p=0.67); I²=0% z=1.10 (p=0.27)
*All analyses fixed effects model and mean difference except depression score (effect is standardised mean difference).
BP, blood pressure; HbA1c, glycated haemoglobin; HR, heart rate.
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which found a 2% reduction in systolic and diastolic from
walking. In comparison, this review of group walking found
reductions of 3% in systolic 5% in diastolic blood pressure,
representing a greater reduction than those from walking alone.
The importance of this difference becomes signiﬁcant when
viewed against ﬁndings that a 2 mm Hg in diastolic blood pres-
sure can reduce coronary heart disease risk by 6% and stroke
and trans-ischaemic attacks by 15%.59 Further evidence of the
importance of this reduction comes from a meta-analysis of pro-
spective studies which suggested that a persistent reduction in
average blood pressure by widely practicable methods could
avoid large absolute numbers of premature deaths and disabling
strokes and a reduction of only 2 mm Hg in systolic blood pres-
sure could reduce stroke mortality by 10% and mortality from
vascular causes in a middle-aged population by 7%.60 Outdoor
walking groups could be an example of such a practicable
method. The second part of this further analysis compared the
results from this systematic review of group walking to a system-
atic review and meta-analysis of pedometers to increase physical
activity and improve health outcomes.61 Again walking groups
were found to have comparable and greater results to those
from pedometers in reductions in BMI, systolic and diastolic
blood pressure and total cholesterol. This was particularly sig-
niﬁcant for diastolic blood pressure with the use of pedometers
showing a reduction of −0.3 mm Hg (−0.02 to −0.46) com-
pared with walking groups −3.14 mm Hg (−4.15 to −2.13). It
should be noted that the two comparator systematic reviews
included outdoor group walking as well as other methods
(indoors and solo) in their meta-analysis; within the systematic
review of pedometers some of the participants may have walked
within a workplace group and additionally people who walk in
groups invariably walk by themselves too. Therefore, this
further analysis is not a straightforward comparison of non-
group versus group methods but this comparison has provided
some evidence that group walking may have beneﬁts to health
at least equal to walking with pedometers and walking per se.
Conclusions and meaning of the study for clinicians
This systematic review with meta-analysis has found that
outdoor walking groups have wide-ranging health beneﬁts. With
low levels of attrition, high levels of adherence and virtually no
adverse effects this study suggests that walking groups could be
a practicable intervention, acceptable to patients as a line of
treatment with a potential for both physiological and psycho-
logical health beneﬁts. It may provide clinicians with evidence
of a further effective option to recommend to those patients
who would beneﬁt from increasing moderate physical activity.
Unanswered questions and further research
One study evaluated the results based on three different walk
speeds.51 Otherwise, there were insufﬁcient studies meeting
moderate activity guidelines from which to conduct a subanaly-
sis and suggest any tentative conclusions about effectiveness of
walking groups and time or intensity. It may be that effect sizes
could be improved by increasing volume and intensity and this
important question remains unanswered. A lack of socio-
economic information prevented analysis of the distribution and
effects between different social groups conﬁrming concerns
raised by Ogilvie et al20 that such targeted interventions may be
preferentially utilised by better-off groups62 and may thereby
increase health inequalities.63 The issue of equity could be
addressed in future research. Additionally, the majority of the
studies in this analysis were with people with diagnosed health
conditions or cardiovascular disease risk factors; therefore, the
potential beneﬁt of walking groups in maintaining good health
in healthy populations is not known. Nevertheless, this review
has shown that there are wide-ranging health beneﬁts from
outdoor walking groups and these appear not to be counterba-
lanced by an increase in injuries or other adverse side effects.
What are the new ﬁndings?
▸ Outdoor walking groups have wide-ranging health beneﬁts
including reducing blood pressure, body fat, total cholesterol
and risk of depression.
▸ Outdoor walking groups appear to be an acceptable
intervention to participants, with high levels of adherence
and virtually no adverse effects.
How might it impact on clinical practice in the near future?
Provides clinicians with evidence of a further effective option to
recommend to those patients who would beneﬁt from
increasing moderate physical activity.
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